BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Subramaniyan M, Dani JA. Dopaminergic and cholinergic learning mechanisms in nicotine addiction. Ann N Y Acad Sci 2015;1349:46-63. [PMID: 26301866 DOI: 10.1111/nyas.12871] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
2 Harmey D, Griffin PR, Kenny PJ. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine Tob Res 2012;14:1300-18. [PMID: 23024249 DOI: 10.1093/ntr/nts201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
3 Carboni L, Ponzoni L, Braida D, Sala M, Gotti C, Zoli M. Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour. Int J Mol Sci 2021;22:E599. [PMID: 33435320 DOI: 10.3390/ijms22020599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen WY, Kao CF, Chen PY, Lin SK, Huang MC. Orexin-A level elevation in recently abstinent male methamphetamine abusers. Psychiatry Res 2016;239:9-11. [PMID: 27137956 DOI: 10.1016/j.psychres.2016.02.059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
5 Balkan B, Pogun S. Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response. Curr Neuropharmacol 2018;16:371-87. [PMID: 28730966 DOI: 10.2174/1570159X15666170720092442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
6 Morgan AJ, Harrod SB, Lacy RT, Stanley EM, Fadel JR. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. Drug Alcohol Depend 2013;132:562-70. [PMID: 23664126 DOI: 10.1016/j.drugalcdep.2013.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
7 Zhang H, Lian Z, Yan S, Bao Y, Liu Z. Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities. Biomed Res Int 2013;2013:282641. [PMID: 24102051 DOI: 10.1155/2013/282641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
8 Alsiö J, Olszewski PK, Levine AS, Schiöth HB. Feed-forward mechanisms: Addiction-like behavioral and molecular adaptations in overeating. Frontiers in Neuroendocrinology 2012;33:127-39. [DOI: 10.1016/j.yfrne.2012.01.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
9 Fragale JE, Pantazis CB, James MH, Aston-Jones G. The role of orexin-1 receptor signaling in demand for the opioid fentanyl. Neuropsychopharmacology 2019;44:1690-7. [PMID: 31112988 DOI: 10.1038/s41386-019-0420-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
10 Jha MK. Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy from a Phase 2B Study of Seltorexant. Int J Neuropsychopharmacol 2021:pyab078. [PMID: 34791262 DOI: 10.1093/ijnp/pyab078] [Reference Citation Analysis]
11 Hollander JA, Pham D, Fowler CD, Kenny PJ. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 2012;6:47. [PMID: 22837742 DOI: 10.3389/fnbeh.2012.00047] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
12 Ferrari A, Zappaterra M, Righi F, Ciccarese M, Tiraferri I, Pini LA, Guerzoni S, Cainazzo MM. Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey. J Headache Pain 2013;14:48. [PMID: 23742010 DOI: 10.1186/1129-2377-14-48] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
13 Smith RJ, Aston-Jones G. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 2012;35:798-804. [PMID: 22356621 DOI: 10.1111/j.1460-9568.2012.08013.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
14 Dehkordi O, Rose JE, Dávila-García MI, Millis RM, Mirzaei SA, Manaye KF, Jayam-Trouth A. Neuroanatomical Relationships between Orexin/Hypocretin-Containing Neurons/Nerve Fibers and Nicotine-Induced c-Fos-Activated Cells of the Reward-Addiction Neurocircuitry. J Alcohol Drug Depend 2017;5:273. [PMID: 29038792 DOI: 10.4172/2329-6488.1000273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
15 Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 2011;70:20-33. [PMID: 21482353 DOI: 10.1016/j.neuron.2011.03.014] [Cited by in Crossref: 131] [Cited by in F6Publishing: 140] [Article Influence: 11.9] [Reference Citation Analysis]
16 Toyoda H. Interaction of nicotinic acetylcholine receptors with dopamine receptors in synaptic plasticity of the mouse insular cortex. Synapse 2019;73:e22094. [PMID: 30767273 DOI: 10.1002/syn.22094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 D'Souza MS. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications. Prog Brain Res 2016;223:191-214. [PMID: 26806777 DOI: 10.1016/bs.pbr.2015.07.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
18 Shahab L, Sarkar BK, West R. The acute effects of yogic breathing exercises on craving and withdrawal symptoms in abstaining smokers. Psychopharmacology (Berl) 2013;225:875-82. [PMID: 22993051 DOI: 10.1007/s00213-012-2876-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
19 Prochaska JJ, Benowitz NL. Current advances in research in treatment and recovery: Nicotine addiction. Sci Adv 2019;5:eaay9763. [PMID: 31663029 DOI: 10.1126/sciadv.aay9763] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
20 Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59. [PMID: 23781178 DOI: 10.3389/fnbeh.2013.00059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
21 Bernardi RE, Zohsel K, Hirth N, Treutlein J, Heilig M, Laucht M, Spanagel R, Sommer WH. A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. Transl Psychiatry 2016;6:e861. [PMID: 27459726 DOI: 10.1038/tp.2016.132] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
22 Dani JA, Jenson D, Broussard JI, De Biasi M. Neurophysiology of Nicotine Addiction. J Addict Res Ther 2011;S1:001. [PMID: 22454789 DOI: 10.4172/2155-6105.S1-001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 0.3] [Reference Citation Analysis]
23 De Biasi M, Dani JA. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 2011;34:105-30. [PMID: 21438686 DOI: 10.1146/annurev-neuro-061010-113734] [Cited by in Crossref: 229] [Cited by in F6Publishing: 223] [Article Influence: 20.8] [Reference Citation Analysis]
24 Coussens NP, Sittampalam GS, Jonson SG, Hall MD, Gorby HE, Tamiz AP, McManus OB, Felder CC, Rasmussen K. The Opioid Crisis and the Future of Addiction and Pain Therapeutics. J Pharmacol Exp Ther 2019;371:396-408. [PMID: 31481516 DOI: 10.1124/jpet.119.259408] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
25 Tsuneki H, Nagata T, Fujita M, Kon K, Wu N, Takatsuki M, Yamaguchi K, Wada T, Nishijo H, Yanagisawa M, Sakurai T, Sasaoka T. Nighttime Administration of Nicotine Improves Hepatic Glucose Metabolism via the Hypothalamic Orexin System in Mice. Endocrinology 2016;157:195-206. [DOI: 10.1210/en.2015-1488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
26 Klein TA, Ullsperger M, Danielmeier C. Error awareness and the insula: links to neurological and psychiatric diseases. Front Hum Neurosci 2013;7:14. [PMID: 23382714 DOI: 10.3389/fnhum.2013.00014] [Cited by in Crossref: 93] [Cited by in F6Publishing: 113] [Article Influence: 10.3] [Reference Citation Analysis]
27 Kutlu MG, Burke D, Slade S, Hall BJ, Rose JE, Levin ED. Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats. Behav Brain Res 2013;256:273-8. [PMID: 23948214 DOI: 10.1016/j.bbr.2013.08.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
28 Hoyer D, Jacobson LH. Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand? Neuropeptides 2013;47:477-88. [DOI: 10.1016/j.npep.2013.10.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
29 Perrey DA, Zhang Y. Therapeutics development for addiction: Orexin-1 receptor antagonists. Brain Res 2020;1731:145922. [PMID: 30148984 DOI: 10.1016/j.brainres.2018.08.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
30 Paolini M, De Biasi M. Mechanistic insights into nicotine withdrawal. Biochem Pharmacol 2011;82:996-1007. [PMID: 21782803 DOI: 10.1016/j.bcp.2011.07.075] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
31 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
32 Usui M, Kaneko K, Oi Y, Kobayashi M. Orexin facilitates GABAergic IPSCs via postsynaptic OX1 receptors coupling to the intracellular PKC signalling cascade in the rat cerebral cortex. Neuropharmacology 2019;149:97-112. [PMID: 30763655 DOI: 10.1016/j.neuropharm.2019.02.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
33 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
34 Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep 2016;39:573-80. [PMID: 26564129 DOI: 10.5665/sleep.5530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
35 Nall RW, Heinsbroek JA, Nentwig TB, Kalivas PW, Bobadilla AC. Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem 2021;157:1450-72. [PMID: 33420731 DOI: 10.1111/jnc.15297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Karila L, Petit A, Zarmdini R, Coscas S, Lowenstein W, Reynaud M. [Tobacco use and illicit substance use disorders: what should we have to do?]. Presse Med 2013;42:795-805. [PMID: 23528335 DOI: 10.1016/j.lpm.2012.11.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
37 Plaza-Zabala A, Flores Á, Maldonado R, Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 2012;71:214-23. [PMID: 21831361 DOI: 10.1016/j.biopsych.2011.06.025] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
38 Toyoda H. Nicotinic activity layer specifically modulates synaptic potentiation in the mouse insular cortex. Eur J Neurosci 2019;50:2211-23. [PMID: 29405451 DOI: 10.1111/ejn.13857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]